This survey is now closed.
We want to thank all who participated in the survey, an international survey, conducted by Ipsen and Carenity. The results will help to better understand the experiences of patients receiving botulinum toxin type A injections.
This survey was especially targeted for people living in Germany, United Kingdom, Italy and France, and was available in these 4 languages.
Italy: https://member.carenity.it/newSurveyBymail/0/20/0/0
Germany: https://member.carenity.de/newSurveyBymail/0/23/0/0
France: https://membre.carenity.com/newSurveyBymail/0/91/0/0
United Kingdom: https://member.carenity.co.uk/newSurveyBymail/0/32/0/0
Your answers may allow us to better understand your experience and identify areas for improving this treatment.
Thank you very much for participating in this survey.
Participation in this survey is unpaid.
To find out more about how your data will be processed and how to exercise your rights, read the survey information page.
